Clinical research organizations help drug companies do the trials to get approval for new products or new indications for existing products, and some help with commercialization services. As with many businesses, the larger ones have tended to cycle between being public companies and being owned by private equity firms. Parexel is one of those firms and is being sold by one PE firm to another one for $8.5 billion.
https://www.fiercebiotech.com/cro/parexel-snapped-up-again-as-goldman-sachs-eqt-spend-8-5b-cro?mkt_tok=Mjk0LU1RRi0wNTYAAAF-JQT8O6i6JHcnk7ZR4kqARM_kPQT30Bp_Pi-_ZxP9MXnJSZsZIewJljp8BmdpYzVSSwDBdoMNCs0dhc-X6h5ScDHGO8eNGQauo1sY_kvsu2odADE&mrkid=635530Olive (is it a vegetable or isn't it?), which offers data analytic services for hospitals and health systems, with a focus on AI, raises another $400 million. The company has raised over $900 million in capital in total and is valued at close to $2 billion. Froth, froth, froth.
https://www.beckershospitalreview.com/artificial-intelligence/olive-raises-400m-hits-4b-valuation.html?origin=CIOE&utm_source=CIOE&utm_medium=email&utm_content=newsletter&oly_enc_id=4013B4524489F1YPaceline raises a fresh $29.5 million in financing to support the 400th company supposedly helping consumers get more engaged in their health and wellness. Great return coming for those investors, not.
https://www.businesswire.com/news/home/20210625005018/en/Paceline-Raises-29.5-Million-in-Series-A-Financing-to-Transform-Traditional-Financial-Services-ModelsMinnesota slips in a change in death reporting to date of death.
Read More
Post-holiday blahs can be lifted by a healthy dose of CV-19 research. Ha-ha.
Read More
This country has been an exceptional beacon of freedom and opportunity for all people around the world.
Read More
A holiday treat of more research summaries, mixed with a couple of observations on our fearful leaders.
Read More
A randomized control, peer-reviewed study in JAMA finds that carbon dioxide levels in children's masks are far above those considered safe.
Read More
A lot of interesting research in the last couple of days, take a couple of posts to catch up.
Read More
Hospitals have list prices far, far above their actual cost of delivering services.
Read More
Venture capital and private equity groups have found ways to buy practices in many medical specialties.
Read More
The national case animation shows shifting geographic patterns.
Read More
The pattern of deaths is pretty similar to that of cases, as you might expect.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts